Clinical Trial Update: Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers [Phase 1]

View source ↗

Summary

Phase 1 open-label study in healthy volunteers to evaluate the effect of rifampin and rifabutin on the pharmacokinetics of GSK1349572 (dolutegravir).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• GSK1349572 (dolutegravir) (dolutegravir)
• RIFABUTIN (Rifabutin)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED